• 1. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

Introduction to 4-(Dimethylamino)-1,2,2,6,6-pentamethylpiperidine (CAS No. 36177-86-3)

4-(Dimethylamino)-1,2,2,6,6-pentamethylpiperidine, identified by the chemical abstracts service number 36177-86-3, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This piperidine derivative features a highly substituted nitrogen-containing heterocycle, making it a versatile intermediate in the development of various pharmacologically active molecules. The structural framework of this compound, characterized by its robust alkyl and amine substituents, imparts unique electronic and steric properties that are exploited in medicinal chemistry.

The compound's molecular structure consists of a six-membered piperidine ring substituted at the 1-position with a secondary amine group ((CH?)?N-) and at the 2-, 2'-, 6-, and 6'-positions with isopropyl groups. This specific arrangement contributes to its stability under a range of chemical conditions while also facilitating interactions with biological targets. The presence of multiple stereocenters and electron-rich regions makes it a valuable scaffold for designing molecules with tailored biological activities.

In recent years, 4-(Dimethylamino)-1,2,2,6,6-pentamethylpiperidine has garnered attention in the synthesis of novel therapeutic agents. Its utility extends to the development of central nervous system (CNS) drugs, where its ability to cross the blood-brain barrier is particularly advantageous. The compound's amine functionality allows for further derivatization via reductive amination or diazotization reactions, enabling the construction of more complex molecules.

One of the most compelling applications of CAS No. 36177-86-3 is in the field of enzyme inhibition. Researchers have leveraged its structural motif to design inhibitors targeting enzymes involved in metabolic pathways and signal transduction cascades. For instance, derivatives of this compound have been explored as potential kinase inhibitors due to their ability to mimic natural substrates or compete with ATP binding sites. The isopropyl groups enhance solubility and metabolic stability, making it an attractive candidate for drug development.

The synthesis of 4-(Dimethylamino)-1,2,2,6,6-pentamethylpiperidine typically involves multi-step organic transformations starting from commercially available precursors such as isopropylamine and cyclohexanone derivatives. Catalytic hydrogenation or metal-catalyzed reactions are commonly employed to construct the piperidine ring system. Advances in synthetic methodologies have enabled more efficient and scalable production processes, which are crucial for industrial applications.

Recent studies have highlighted the role of this compound in medicinal chemistry beyond traditional drug development. Its structural features make it an excellent ligand for biochemical assays and high-throughput screening (HTS) platforms. By serving as a probe molecule, researchers can identify new binding partners and explore mechanisms of action for various therapeutic targets. This has accelerated the discovery pipeline for small-molecule drugs.

The pharmacokinetic profile of CAS No. 36177-86-3 derivatives is another area of active investigation. Understanding how structural modifications influence absorption, distribution, metabolism, excretion (ADME), and toxicity (ADMET) properties is essential for optimizing drug candidates. Computational modeling and experimental studies have demonstrated that subtle changes in substituent placement can significantly impact these parameters.

In conclusion,4-(Dimethylamino)-1,2,2,6,6-pentamethylpiperidine (CAS No. 36177-86-3) represents a cornerstone in modern pharmaceutical research. Its unique structural attributes enable diverse applications in drug discovery and molecular probe design. As synthetic techniques continue to evolve and our understanding of biological systems deepens,this compound will undoubtedly remain at the forefront of innovation in medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)